On Saturday, 29 January 2022,Knowledge Ecology International (KEI) delivered the following statement on the Global strategy and plan of action on public health, innovation and intellectual property at the 150th session of the World Health Organization’s Executive Board. Access to… Continue Reading
On Wednesday, 26 January 2022, Knowledge Ecology International (KEI) delivered the following statement on the Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases and WHO’s roadmap for the global… Continue Reading
On Wednesday, 26 January 2022, Knowledge Ecology International (KEI) delivered the following statement on a possible pandemic treaty at the 150th session of the World Health Organization’s Executive Board. The WHO negotiations on a pandemic treaty are not a quick… Continue Reading
(For more information, please see the Xtandi: 2021-2022 request page) A January 25, 2022 Knowledge Ecology International “Memorandum in support of the petition to HHS to exercise the march-in or paid up royalty right in patents on the prostate drug… Continue Reading
New: March 21, 2023. The NIH sent a response to the Xtandi petition, rejecting the request to use the governments’ rights to lower the price of the prostate cancer treatment. New: March 23, 2023. The petitioners filed an appeal to… Continue Reading
On Wednesday January 12, 2022, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding a prospective exclusive, sublicensable license to the University of Louisville Research Foundation (ULRF), for “Griffithsin Compositions for Treatment and Prevention of… Continue Reading
Update: Video recording of the press briefing available here: https://www.youtube.com/watch?v=KwqUl7NLMXo) December 15th 10AM – Briefing on Xtandi March-in Request Supporters of the march-in petition to lower the cost of the prostate cancer drug Xtandi will host a virtual press conference… Continue Reading
On December 13, 2021, Eric Sawyer filed this petition with the Department of Health and Human Services, asking to join an outstanding march-in petition on the patents for the prostate cancer drug enzalutamide, sold under the brand name Xtandi by… Continue Reading
(Update: On December 15, 2021 KEI hosted a press briefing regarding the Xtandi march-in request. Video and details available here: https://www.youtube.com/watch?v=KwqUl7NLMXo) On November 18, 2021, Robert Sachs and Clare Love submitted a petition to the Secretary of Health and Human… Continue Reading
